Skip to main content
SpringerLink
Log in

Slow Progress in Predicting and Preventing Fatal Gastric Cancer Peritoneal Recurrence

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.

    Article  PubMed  CAS  Google Scholar 

  2. Sun Z, Xu YY, Wang ZN, et al. Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery. Ann Surg Oncol. 2011;18:1068–80.

    Article  PubMed  Google Scholar 

  3. Li X, Zhang Y, Zhang Y, Ding J, Wu K, Fan D. Survival prediction of gastric cancer by a seven-microRNA signature. Gut. 2010;59:579–85.

    Article  PubMed  CAS  Google Scholar 

  4. Roukos DH. Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn. 2010;10(3):247–50.

    Article  PubMed  Google Scholar 

  5. Roukos DH. Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks. Pharmacogenomics J. 2011;11(2):81–92.

    Article  PubMed  CAS  Google Scholar 

  6. Roukos DH. Next-generation sequencing and epigenome technologies: potential medical applications. Expert Rev Med Devices. 2010;7(6):723–6.

    Article  PubMed  CAS  Google Scholar 

  7. Roukos DH. Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics. 2010;11(8):1039–43.

    Article  PubMed  CAS  Google Scholar 

  8. Roukos DH. Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice. Biomark Med. 2010;4(4):583–6.

    Article  PubMed  Google Scholar 

  9. Katsios C, Roukos DH. Individual genomes and personalized medicine: life diversity and complexity. Per Med. 2010;7(4):347–50.

    Article  CAS  Google Scholar 

  10. Roukos DH, Katsios C, Liakakos T. Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn. 2010;10(5):541–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, “METAXA” Cancer Memorial Hospital, Piraeus, Greece

    John Spiliotis MD

  2. Department of Gynaecology, “METAXA” Cancer Memorial Hospital, Piraeus, Greece

    Eugenia Halkia MD

Authors
  1. John Spiliotis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eugenia Halkia MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John Spiliotis MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spiliotis, J., Halkia, E. Slow Progress in Predicting and Preventing Fatal Gastric Cancer Peritoneal Recurrence. Ann Surg Oncol 18 (Suppl 3), 200–201 (2011). https://doi.org/10.1245/s10434-011-1851-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-011-1851-8

Keywords

Search

Navigation